APA

Bardia A., Aftimos P., Bihani T., Anderson-Villaluz A. T., Jung J., Conlan M. G. & Kaklamani V. G. (20200409). EMERALD: Phase III trial of elacestrant (RAD1901) vs endocrine therapy for previously treated ER+ advanced breast cancer. : Future oncology (London, England).

Chicago

Bardia Aditya, Aftimos Philippe, Bihani Teeru, Anderson-Villaluz Alfred T, Jung JungAh, Conlan Maureen G and Kaklamani Virginia G. 20200409. EMERALD: Phase III trial of elacestrant (RAD1901) vs endocrine therapy for previously treated ER+ advanced breast cancer. : Future oncology (London, England).

Harvard

Bardia A., Aftimos P., Bihani T., Anderson-Villaluz A. T., Jung J., Conlan M. G. and Kaklamani V. G. (20200409). EMERALD: Phase III trial of elacestrant (RAD1901) vs endocrine therapy for previously treated ER+ advanced breast cancer. : Future oncology (London, England).

MLA

Bardia Aditya, Aftimos Philippe, Bihani Teeru, Anderson-Villaluz Alfred T, Jung JungAh, Conlan Maureen G and Kaklamani Virginia G. EMERALD: Phase III trial of elacestrant (RAD1901) vs endocrine therapy for previously treated ER+ advanced breast cancer. : Future oncology (London, England). 20200409.